ZMapp was perhaps the most sought-after drug at the height of the Ebola crisis, but a clinical trial has failed to prove that patients who got the experimental medication were helped by it.
Among 36 patients who were randomly assigned to receive ZMapp in addition to the standard therapy available...
via L.A. Times - Science http://ift.tt/2ejL7ce
No comments:
Post a Comment